行业资讯 -尊龙凯时平台入口
the food enzyme, a maltogenic amylase (glucan 1,4‐α‐maltohydrolase; ec 3.2.1.133), is produced with a genetically modified escherichia coli strain blasc by advanced enzyme technologies ltd. the genetic modifications do not give rise to safety concerns. the food enzyme is free from viable cells of the production organism and recombinant dna. this maltogenic amylase is intended to be used in baking and brewing processes and starch processing for the production of glucose syrups. residual amounts of total organic solids (tos) are removed by the purification steps applied during the production of glucose syrups; consequently, dietary exposure was not calculated for this food process. for baking and brewing processes, based on the maximum use levels recommended for food processes and individual data from the efsa comprehensive european food database, dietary exposure to the food enzyme-tos was estimated to be up to 0.107 mg tos/kg body weight (bw) per day.
文章来源:食品伙伴网
- 《2020年保健品行业白皮书》: 以营养保健食品维持健康成为一种生活方式 2020-05-29
- 全国保健食品生产企业体系检查推进会 在宁波召开 2021-09-17
- 沙特阿拉伯修订保健品等生产企业注册原则 2022-11-29
- 关于批准《植物肽》团体标准项目立项的公告 2021-11-23
- 美国拟扩大螺旋藻提取物的使用范围 2020-05-14